Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program

Charu Mehta, MS, Kirby D Johnson, Xin Gao, Irene Ong, Koichi Ricardo Katsumura, MD PhD, Skye Courtney McIver, PhD, Erik A. Ranheim, MD PhD, Emery H Bresnick, PhD

Blood (2017) 130 (Supplement 1): 7.

https://doi.org/10.1182/blood.V130.Suppl_1.7.7

Published: 2017

Journal Articles

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Yan-Hua Wang, MD PhD, Toshiko Motoji, MD PhD, Yoichi Imai, MD PhD, Masayuki Shiseki, MD PhD, Kenjiro Mitsuhashi, MD, Ye Ding, MD, Junji Tanaka, MD PhD

Blood (2014) 124 (21): 2225.

https://doi.org/10.1182/blood.V124.21.2225.2225

Published: 2014

Journal Articles

Wnt Signaling Is Associated with Anti-Apoptosis in the Interaction Between Acute Myeloid Leukemia Cells and Stromal Cells

Yosuke Minami, MD, PhD, Yosuke Niwa, Akihiro Abe, MD, PhD, Fumihiko Hayakawa, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 1366.

https://doi.org/10.1182/blood.V120.21.1366.1366

Published: 2012

Journal Articles

Noncanonical Wnt Signaling Maintains Hematopoietic Stem Cells in Different Zones

Ryohichi Sugimura, MD, Linheng Li, PhD

Blood (2012) 120 (21): 639.

https://doi.org/10.1182/blood.V120.21.639.639

Published: 2012

Journal Articles

Non-Canonical Wnt Signaling Regulates Hematopooetic Repopulation Through the Ryk Receptor

Benjamin Povinelli, Michael J. Nemeth, PhD

Blood (2012) 120 (21): 852.

https://doi.org/10.1182/blood.V120.21.852.852

Published: 2012

Journal Articles

Microenvironmental Protection of CML Stem and Progenitor Cells From Tyrosine Kinase Inhibitors Through N-Cadherin and Wnt Signaling

Bin Zhang, Tinisha McDonald, B.S., Tessa L. Holyoake, PhD, FRCP, FRCPath, Randall T Moon, PHD, Dario Campana, MD, PhD, Leonard Shultz, PhD, Ravi Bhatia, MD

Blood (2012) 120 (21): 912.

https://doi.org/10.1182/blood.V120.21.912.912

Published: 2012

Journal Articles

Primary Bone Marrow-Derived MSC Subsets Have Distinct Wnt-Signatures Compared to Conventionally Cultured MSC and Differ in Their Capacity to Support Hematopoiesis in Vitro ,

Marijke W Maijenburg, Marion Kleijer, Kim Vermeul, Erik P.J. Mul, Floris P.J. van Alphen, C. Ellen van der Schoot, MD, PhD, Carlijn Voermans, PhD

Blood (2011) 118 (21): 3414.

https://doi.org/10.1182/blood.V118.21.3414.3414

Published: 2011

Journal Articles

Secreted Frizzled-Related Protein-3 (sFRP3) Is Produced by Myeloma Cells and Augments Wnt3a-Induced Differentiation of Mesenchymal Stem Cells and OPG Production in Osteoblasts

Ya-Wei Qiang, MD, PhD, Yu Chen, Bo Hu, PhD, Wei Qiang, MD, Christoph Heuck, MD, Shmuel Yaccoby, PhD, Joshua Epstein, DSc, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., PhD

Blood (2011) 118 (21): 808.

https://doi.org/10.1182/blood.V118.21.808.808

Published: 2011

Journal Articles

Whole Genome Sequencing Identifies Functional Mutations In the Wnt Pathway In CLL

Lili Wang, Nathalie Pochet, Kristian Cibulskis, Wandi Zhang, Mike Lawrence, Quinlan L. Sievers, Erica Shefler, Donna Neuberg, ScD, Stacey Gabriel, Carrie Sougnez, Aviv Regev, Gad Getz, Nir Hacohen, Jennifer R Brown, MD, PhD, Catherine J Wu, MD

Blood (2010) 116 (21): 693.

https://doi.org/10.1182/blood.V116.21.693.693

Published: 2010

Journal Articles

Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) - a Putative Diagnostic Marker for Chronic Lymphocytic Leukemia (CLL).

Sabrina Uhrmacher, Magdalena Hertweck, Julian Paesler, M.Pharm., Felix Erdfelder, Alexandra Filipovich, Simon Jonas Poll-Wolbeck, Regina Razavi, M.Pharm., Rajesh Kumar Gandhirajan, M.Sc., Iris Gehrke, Michael Hallek, MD, Karl Anton Kreuzer, MD

Blood (2009) 114 (22): 1587.

https://doi.org/10.1182/blood.V114.22.1587.1587

Published: 2009

Journal Articles

Transcriptional Down-Regulation of the Wnt Antagonist SFRP1 Is Associated to Promoter Hypermethylation as Detected by Pyrosequencing in Hematopoietic Cells of Patients with Different Risk-Types of MDS, ALL and AML.

Jana Reins, Maximilian Mossner, Uwe Platzbecker, Eckhard Thiel, Wolf-Karsten Hofmann

Blood (2009) 114 (22): 1751.

https://doi.org/10.1182/blood.V114.22.1751.1751

Published: 2009

Journal Articles

Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma

Pascal Gelebart, Mona Anand, Hanan Armanious, Anthea C. Peters, Jennifer Dien Bard, Hesham M. Amin, Raymond Lai

Blood (2008) 112 (13): 5171–5179.

https://doi.org/10.1182/blood-2008-02-139212

Published: 2008

Journal Articles

Influence of PI-3K/Akt Pathway on Wnt Signalling in Myeloid Progenitor Cells. Evidence for a Role of Autocrine/Paracrine Wnt Regulation in CFU-GM Proliferation

Georgios Nteliopoulos, MSc, Stephen B Marley, PhD, Myrtle Y Gordon, PhD, DSc

Blood (2008) 112 (11): 2892.

https://doi.org/10.1182/blood.V112.11.2892.2892

Published: 2008

Journal Articles

Wnt3 Signaling Augments integrinβ1-Dependent Adhesion-Mediated Drug Resistance of Multiple Myeloma in Autocrine and Paracrine Manner.

Masayoshi Kobune, MD, PhD, Kazuyuki Murase, MD, PhD, Satoshi Iyama, MD, PhD, Tsutomu Sato, MD, PhD, Yutaka Kawano, MD, PhD, Shohei Kikuchi, MD, PhD, Koji Miyanishi, MD, PhD, Rishu Takimoto, MD, PhD, Junji Kato, MD, PhD

Blood (2008) 112 (11): 1698.

https://doi.org/10.1182/blood.V112.11.1698.1698

Published: 2008

Journal Articles

Role of GSK3 in Multiple Myeloma Cell Growth and Survival.

Francesco A. Piazza, MD, Carmela Gurrieri, MD, Gino Chioetto, B.S., Anna Colpo, MD, Luca Bonanni, MD, Barbara Montini, PhD, Laura Quotti Tubi, B.S., Marianna Gnoato, B.S., Samuela Carraro, B.S., Anna Cabrelle, PhD, Livio Trentin, MD, Renato Zambello, MD, Gianpietro Semenzato

Blood (2007) 110 (11): 2509.

https://doi.org/10.1182/blood.V110.11.2509.2509

Published: 2007

Journal Articles

Wnt3 / RhoA / ROCK Signaling Pathway Is Involved in VLA6-Dependent Adhesion-Mediated Drug Resistance of Multiple Myeloma.

Masayoshi Kobune, MD, PhD, Yutaka Kawano, MD, PhD, Rishu Takimoto, MD, PhD, Takuya Matsunaga, MD, PhD, Junji Kato, MD, PhD, Hirofumi Hamada, MD, PhD, Yoshiro Niitsu, MD, PhD

Blood (2007) 110 (11): 2518.

https://doi.org/10.1182/blood.V110.11.2518.2518

Published: 2007

Journal Articles

Analysis of the Role of Wnt Signaling for the Interaction between Leukemia Cells and Stroma.

Akihiro Abe, MD, PhD, Yosuke Niwa, Jinglan Xu, MD & PhD, Momoko Suzuki, MD, Fumihiko Hayakawa, MD & PhD, Akira Katsumi, MD & PhD, Hitoshi Kiyoi, MD & PhD, Tomoki Naoe, MD & PhD

Blood (2007) 110 (11): 4314.

https://doi.org/10.1182/blood.V110.11.4314.4314

Published: 2007

Journal Articles

The Wnt Pathway Modulates Expression of Growth and Survival Genes in Acute Lymphoblastic Leukemia Cells.

Naveed I. Khan, BSc (Hons), Kenneth Francis Bradstock, MBBS PhD, Linda J. Bendall, BSc, PhD

Blood (2006) 108 (11): 1850.

https://doi.org/10.1182/blood.V108.11.1850.1850

Published: 2006

Journal Articles

Expression of Wnt-3a in Myeloma Cells Inhibits the Osteolytic Phenotype In-Vivo.

Ya-Wei Qiang, Shmuel Yaccoby, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3420.

https://doi.org/10.1182/blood.V108.11.3420.3420

Published: 2006

Journal Articles

Toward Defining the Functional Relevance of Wnt Signaling in Osteoclasts in Multiple Myeloma.

Ya-Wei Qiang, Yu Chen, Nathan Brown, Rohit P. Ojha, Stuart Rudikoff, Bart Barlogie, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3422.

https://doi.org/10.1182/blood.V108.11.3422.3422

Published: 2006

NARROW

Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program

Knockdown of a Wnt Receptor FZD1 reduces MDR1 /P-Glycoprotein Expression in Human Leukemia Cells through the Wnt/β-Catenin Signaling Pathway

Wnt Signaling Is Associated with Anti-Apoptosis in the Interaction Between Acute Myeloid Leukemia Cells and Stromal Cells

Noncanonical Wnt Signaling Maintains Hematopoietic Stem Cells in Different Zones

Non-Canonical Wnt Signaling Regulates Hematopooetic Repopulation Through the Ryk Receptor

Microenvironmental Protection of CML Stem and Progenitor Cells From Tyrosine Kinase Inhibitors Through N-Cadherin and Wnt Signaling

Primary Bone Marrow-Derived MSC Subsets Have Distinct Wnt-Signatures Compared to Conventionally Cultured MSC and Differ in Their Capacity to Support Hematopoiesis in Vitro ,

Secreted Frizzled-Related Protein-3 (sFRP3) Is Produced by Myeloma Cells and Augments Wnt3a-Induced Differentiation of Mesenchymal Stem Cells and OPG Production in Osteoblasts

Whole Genome Sequencing Identifies Functional Mutations In the Wnt Pathway In CLL

Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) - a Putative Diagnostic Marker for Chronic Lymphocytic Leukemia (CLL).

Transcriptional Down-Regulation of the Wnt Antagonist SFRP1 Is Associated to Promoter Hypermethylation as Detected by Pyrosequencing in Hematopoietic Cells of Patients with Different Risk-Types of MDS, ALL and AML.

Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma

Influence of PI-3K/Akt Pathway on Wnt Signalling in Myeloid Progenitor Cells. Evidence for a Role of Autocrine/Paracrine Wnt Regulation in CFU-GM Proliferation

Wnt3 Signaling Augments integrinβ1-Dependent Adhesion-Mediated Drug Resistance of Multiple Myeloma in Autocrine and Paracrine Manner.

Role of GSK3 in Multiple Myeloma Cell Growth and Survival.

Wnt3 / RhoA / ROCK Signaling Pathway Is Involved in VLA6-Dependent Adhesion-Mediated Drug Resistance of Multiple Myeloma.

Analysis of the Role of Wnt Signaling for the Interaction between Leukemia Cells and Stroma.

The Wnt Pathway Modulates Expression of Growth and Survival Genes in Acute Lymphoblastic Leukemia Cells.

Expression of Wnt-3a in Myeloma Cells Inhibits the Osteolytic Phenotype In-Vivo.

Toward Defining the Functional Relevance of Wnt Signaling in Osteoclasts in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only